Automated microfluidic platform of bead-based electrochemical immunosensor integrated with bioreactor for continual monitoring of cell secreted biomarkers
View/ Open
Author
Riahi, Reza
Shaegh, Seyed Ali Mousavi
Ghaderi, Masoumeh
Zhang, Yu Shrike
Shin, Su Ryon
Aleman, Julio
Massa, Solange
Kim, Duckjin
Published Version
https://doi.org/10.1038/srep24598Metadata
Show full item recordCitation
Riahi, Reza, Seyed Ali Mousavi Shaegh, Masoumeh Ghaderi, Yu Shrike Zhang, Su Ryon Shin, Julio Aleman, Solange Massa, Duckjin Kim, Mehmet Remzi Dokmeci, and Ali Khademhosseini. 2016. “Automated microfluidic platform of bead-based electrochemical immunosensor integrated with bioreactor for continual monitoring of cell secreted biomarkers.” Scientific Reports 6 (1): 24598. doi:10.1038/srep24598. http://dx.doi.org/10.1038/srep24598.Abstract
There is an increasing interest in developing microfluidic bioreactors and organs-on-a-chip platforms combined with sensing capabilities for continual monitoring of cell-secreted biomarkers. Conventional approaches such as ELISA and mass spectroscopy cannot satisfy the needs of continual monitoring as they are labor-intensive and not easily integrable with low-volume bioreactors. This paper reports on the development of an automated microfluidic bead-based electrochemical immunosensor for in-line measurement of cell-secreted biomarkers. For the operation of the multi-use immunosensor, disposable magnetic microbeads were used to immobilize biomarker-recognition molecules. Microvalves were further integrated in the microfluidic immunosensor chip to achieve programmable operations of the immunoassay including bead loading and unloading, binding, washing, and electrochemical sensing. The platform allowed convenient integration of the immunosensor with liver-on-chips to carry out continual quantification of biomarkers secreted from hepatocytes. Transferrin and albumin productions were monitored during a 5-day hepatotoxicity assessment in which human primary hepatocytes cultured in the bioreactor were treated with acetaminophen. Taken together, our unique microfluidic immunosensor provides a new platform for in-line detection of biomarkers in low volumes and long-term in vitro assessments of cellular functions in microfluidic bioreactors and organs-on-chips.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838915/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:26860051
Collections
- HMS Scholarly Articles [17917]
Contact administrator regarding this item (to report mistakes or request changes)